Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s site revision changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 error rather than the study record.SummaryDifference0.2%

- Check22 days agoChange DetectedA 403 Forbidden message appears in place of the clinical study record, with a Home button below it.SummaryDifference0.5%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error page with the 403 header and related HTML markup, instead of showing the study record content. This indicates an access issue to the page rather than any update to the study information.SummaryDifference20%

- Check56 days agoChange DetectedThe page's revision metadata now shows the latest revision as v3.6.6, replacing the previous v3.6.5. This reflects an administrative update to the page's version history rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.